NYSEAMERICAN : ARMP
Armata Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 3.44 USD (Oct 30, 2026, 9:30 AM EDT) · Market cap 127.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Armata Pharmaceuticals, Inc. (ARMP) reported revenue of 5.54M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 5.54M | 4.90M | 5.17M | 4.53M | 5.51M | 4.47M |
| Cost of Revenue | 17.59M | 15.72M | 26.03M | 33.77M | 35.02M | 20.02M |
| Gross Profit | -12.05M | -10.81M | -20.85M | -29.24M | -29.51M | -15.54M |
| Selling, General & Admin | 23.24M | 20.41M | 21.58M | 11.65M | 7.44M | 8.28M |
| Operating Expenses | 23.24M | 20.41M | 21.58M | 11.65M | 7.44M | 8.28M |
| Operating Income | -35.28M | -31.22M | -42.44M | -40.89M | -36.95M | -23.82M |
| Interest Expense | -21.37M | -16.59M | -10.74M | -2.63M | -64.00K | |
| Interest & Investment Income | 350.00K | 388.00K | 697.00K | 179.00K | 29.00K | 5.00K |
| EBT Excluding Unusual Items | -56.31M | -47.42M | -52.48M | -43.34M | -36.92M | -23.88M |
| Asset Writedown | -5.41M | -5.41M | ||||
| Other Unusual Items | -130.46M | -120.96M | 33.56M | -25.71M | 726.00K | |
| Pretax Income | -192.18M | -173.80M | -18.92M | -69.05M | -36.92M | -23.16M |
| Net Income | -192.18M | -173.80M | -18.92M | -69.05M | -36.92M | -23.16M |
| Net Income to Common | -192.18M | -173.80M | -18.92M | -69.05M | -36.92M | -23.16M |
| Shares Outstanding (Basic) | 36.46M | 36.24M | 36.16M | 36.08M | 34.29M | 24.10M |
| Shares Outstanding (Diluted) | 36.46M | 36.24M | 59.06M | 36.08M | 34.29M | 24.10M |
| EPS (Basic) | -5.27 | -4.80 | -0.52 | -1.91 | -1.08 | -0.96 |
| EPS (Diluted) | -5.27 | -4.80 | -0.89 | -1.91 | -1.08 | -0.96 |
| Free Cash Flow | -25.79M | -26.30M | -39.43M | -55.57M | -34.69M | -24.88M |
| Free Cash Flow Per Share | -0.71 | -0.73 | -0.67 | -1.54 | -1.01 | -1.03 |
| Gross Margin | -217.36% | -220.49% | ||||
| Operating Margin | -636.55% | -636.66% | -820.18% | -902.85% | -670.77% | -532.45% |
| Profit Margin | -3,467.04% | -3,544.03% | -365.60% | -1,524.51% | -670.24% | -517.55% |
| Free Cash Flow Margin | -465.34% | -536.40% | -762.08% | -1,226.91% | -629.85% | -556.08% |
| EBITDA | -33.45M | -29.69M | -41.11M | -39.92M | -36.05M | -22.65M |
| D&A For EBITDA | 1.84M | 1.53M | 1.32M | 972.00K | 892.00K | 1.17M |
| EBIT | -35.28M | -31.22M | -42.44M | -40.89M | -36.95M | -23.82M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 23.95M | 8.69M | 9.29M | 13.52M | 14.85M | 10.29M |
| Cash & Short-Term Investments | 23.95M | 8.69M | 9.29M | 13.52M | 14.85M | 10.29M |
| Other Receivables | 2.53M | 472.00K | 744.00K | 3.36M | 8.53M | 2.99M |
| Receivables | 2.53M | 472.00K | 744.00K | 3.36M | 8.53M | 2.99M |
| Prepaid Expenses | 673.00K | 1.51M | 1.27M | 2.27M | 3.66M | 1.72M |
| Total Current Assets | 27.16M | 10.67M | 11.31M | 19.15M | 27.05M | 14.99M |
| Property, Plant & Equipment | 44.11M | 46.10M | 54.93M | 57.28M | 46.65M | 38.07M |
| Goodwill | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M |
| Long-Term Deferred Charges | 10.26M | 10.26M | 10.26M | 10.26M | 10.26M | 10.26M |
| Other Long-Term Assets | 4.93M | 6.36M | 6.46M | 8.19M | 8.39M | 2.96M |
| Total Assets | 89.95M | 76.88M | 86.44M | 98.36M | 95.83M | 69.77M |
| Accounts Payable | 1.19M | 921.00K | 766.00K | 1.58M | 1.68M | 1.14M |
| Accrued Expenses | 2.71M | 2.98M | 3.57M | 4.87M | 6.18M | 2.17M |
| Current Portion of Long-Term Debt | 241.48M | 38.95M | ||||
| Current Portion of Leases | 4.62M | 4.56M | 4.43M | 9.48M | 17.01M | 1.51M |
| Other Current Liabilities | 195.00K | 487.00K | 529.00K | 523.00K | ||
| Total Current Liabilities | 250.20M | 8.95M | 48.25M | 16.46M | 24.87M | 4.81M |
| Long-Term Debt | 42.02M | 256.92M | 55.44M | 82.31M | ||
| Long-Term Leases | 25.82M | 26.53M | 27.69M | 28.58M | 31.80M | 36.48M |
| Long-Term Deferred Tax Liabilities | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M |
| Total Liabilities | 321.12M | 295.48M | 134.46M | 130.43M | 59.75M | 44.37M |
| Common Stock | 371.00K | 364.00K | 362.00K | 361.00K | 361.00K | 271.00K |
| Additional Paid-In Capital | 311.19M | 282.57M | 279.35M | 276.39M | 275.49M | 227.98M |
| Retained Earnings | -542.74M | -501.53M | -327.74M | -308.82M | -239.77M | -202.86M |
| Shareholders' Equity | -231.17M | -218.60M | -48.02M | -32.06M | 36.08M | 25.40M |
| Total Liabilities & Equity | 89.95M | 76.88M | 86.44M | 98.36M | 95.83M | 69.77M |
| Total Debt | 313.95M | 288.02M | 126.52M | 120.37M | 48.81M | 37.99M |
| Net Cash (Debt) | -290.00M | -279.33M | -117.22M | -106.85M | -33.96M | -27.70M |
| Net Cash Per Share | -7.95 | -7.71 | -1.98 | -2.96 | -0.99 | -1.15 |
| Filing Date Shares Outstanding | 37.18M | 36.63M | 36.18M | 36.15M | 36.14M | 30.73M |
| Total Common Shares Outstanding | 37.15M | 36.43M | 36.18M | 36.12M | 36.14M | 27.11M |
| Working Capital | -223.04M | 1.72M | -36.94M | 2.69M | 2.17M | 10.18M |
| Book Value Per Share | -6.22 | -6.00 | -1.33 | -0.89 | 1.00 | 0.94 |
| Tangible Book Value | -234.66M | -222.09M | -51.51M | -35.55M | 32.59M | 21.91M |
| Tangible Book Value Per Share | -6.32 | -6.10 | -1.42 | -0.98 | 0.90 | 0.81 |
| Machinery | 19.02M | 22.43M | 22.59M | 12.83M | 11.27M | 9.02M |
| Construction In Progress | 3.50M | 8.10M | ||||
| Leasehold Improvements | 3.81M | 3.80M | 3.80M | 3.45M | 3.45M | 3.42M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -192.18M | -173.80M | -18.92M | -69.05M | -36.92M | -23.16M |
| Depreciation & Amortization | 1.84M | 1.53M | 1.32M | 972.00K | 892.00K | 1.17M |
| Loss (Gain) From Sale of Assets | 81.00K | |||||
| Asset Writedown & Restructuring Costs | 5.41M | 5.41M | ||||
| Stock-Based Compensation | 5.72M | 2.61M | 2.89M | 938.00K | 3.10M | 2.88M |
| Other Operating Activities | 154.02M | 139.90M | -20.75M | 29.28M | -1.25M | |
| Change in Accounts Payable | 338.00K | -334.00K | -3.75M | 39.00K | 3.67M | 184.00K |
| Change in Other Net Operating Assets | -568.00K | -1.08M | 1.66M | -9.69M | -3.23M | -3.41M |
| Operating Cash Flow | -25.42M | -25.76M | -37.55M | -47.42M | -32.48M | -23.57M |
| Capital Expenditures | -374.00K | -542.00K | -1.88M | -8.14M | -2.21M | -1.30M |
| Sale of Property, Plant & Equipment | 10.00K | |||||
| Investing Cash Flow | -374.00K | -542.00K | -1.88M | -8.13M | -2.21M | -1.30M |
| Long-Term Debt Issued | 25.00M | 34.89M | 54.03M | |||
| Total Debt Issued | 40.00M | 25.00M | 34.89M | 54.03M | ||
| Net Debt Issued (Repaid) | 40.00M | 25.00M | 34.89M | 54.03M | ||
| Issuance of Common Stock | 4.24M | 658.00K | 130.00K | 5.00K | 44.52M | 26.93M |
| Repurchase of Common Stock | -95.00K | -46.00K | -61.00K | -43.00K | ||
| Other Financing Activities | -500.00K | -1.41M | ||||
| Financing Cash Flow | 44.15M | 25.61M | 34.96M | 53.99M | 44.02M | 25.52M |
| Net Cash Flow | 18.35M | -693.00K | -4.47M | -1.57M | 9.32M | 639.00K |
| Free Cash Flow | -25.79M | -26.30M | -39.43M | -55.57M | -34.69M | -24.88M |
| Free Cash Flow Margin | -465.34% | -536.40% | -762.08% | -1,226.91% | -629.85% | -556.08% |
| Free Cash Flow Per Share | -0.71 | -0.73 | -0.67 | -1.54 | -1.01 | -1.03 |
| Levered Free Cash Flow | -27.41M | -26.73M | -29.40M | -27.75M | -24.24M | -16.82M |
| Unlevered Free Cash Flow | -14.05M | -16.36M | -22.69M | -26.11M | -24.24M | -16.78M |
| Change in Working Capital | -230.00K | -1.41M | -2.10M | -9.65M | 439.00K | -3.22M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 121.96M | 228.64M | 66.94M | 117.11M | 44.82M | 148.43M |
| Enterprise Value | 411.96M | 391.56M | 190.12M | 206.79M | 58.88M | 148.67M |
| Last Close Price | 3.28 | 6.28 | 1.85 | 3.24 | 1.24 | 5.48 |
| PS Ratio | 22.00 | 46.62 | 12.94 | 25.86 | 8.14 | 33.18 |
| PB Ratio | -1.05 | -1.39 | -3.65 | 1.24 | 5.84 | |
| P/TBV Ratio | 1.38 | 6.78 | ||||
| EV/Sales Ratio | 74.32 | 79.84 | 36.75 | 45.66 | 10.69 | 33.23 |
| Debt / Equity Ratio | -1.36 | -1.32 | -2.63 | -3.75 | 1.35 | 1.50 |
| Net Debt / Equity Ratio | -1.25 | -1.28 | -2.44 | -3.33 | 0.94 | 1.09 |
| Net Debt / EBITDA Ratio | -8.67 | -9.41 | -2.85 | -2.68 | -0.94 | -1.22 |
| Net Debt / FCF Ratio | -11.24 | -10.62 | -2.97 | -1.92 | -0.98 | -1.11 |
| Asset Turnover | 0.07 | 0.06 | 0.06 | 0.05 | 0.07 | 0.08 |
| Quick Ratio | 0.11 | 1.02 | 0.21 | 1.03 | 0.94 | 2.76 |
| Current Ratio | 0.11 | 1.19 | 0.23 | 1.16 | 1.09 | 3.12 |
| Return on Equity (ROE) | -3,439.35% | -120.10% | -104.65% | |||
| Return on Assets (ROA) | -25.83% | -23.90% | -28.70% | -26.32% | -27.89% | -27.25% |
| Return on Capital Employed (ROCE) | 22.00% | -46.00% | -111.10% | -49.90% | -52.10% | -36.70% |
| Earnings Yield | -160.69% | -76.02% | -28.26% | -58.95% | -82.37% | -15.60% |
| FCF Yield | -21.15% | -11.51% | -58.90% | -47.45% | -77.40% | -16.76% |
| Buyback Yield / Dilution | -0.77% | 38.64% | -63.71% | -5.20% | -42.27% | -46.84% |